Compare TD SYNNEX Corporation Common Stock (SNX) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
TD SYNNEX Corporation Common Stock vs Vir Biotechnology Inc. Common Stock — how do they compare? TD SYNNEX Corporation Common Stock trades at $262 (market cap $22.02B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: TD SYNNEX Corporation Common Stock is far larger — about 12.2× Vir Biotechnology Inc. Common Stock's market cap, and TD SYNNEX Corporation Common Stock pays a 0.7% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold TD SYNNEX Corporation Common Stock for 0 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| SNX | VIR | |
|---|---|---|
Market Cap | $22.02B | $1.80B |
Volume | 614,208 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $290.14 | $11.78 |
52-Week Low | $142.42 | $5.12 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $26.79B | $1.36B |
Dividend Yield | 0.7% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About TD SYNNEX Corporation Common Stock
TD SYNNEX Corporation is a global IT distributor and solutions aggregator that distributes endpoint devices and data-center technologies from technology vendors to resellers and customers worldwide.
Read more on SNX →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
